French breast implant boss arrested
Key points
- Jean-Claude Mas, the Frenchman who sparked a global health scare by selling substandard breast implants, was arrested on Thursday as Marseille prosecutors build a case against him for manslaughter.
- PIP enjoyed years of success with international sales, but behind the scenes employees, and Mas himself, have admitted to hiding from certification agencies the fact they were using cheap, industrial silicone, not approved for medical use.
- In the first arrests since the two-year-old scandal made headlines worldwide in December, Mas and a second executive at his now defunct company Poly Implant Prothese (PIP) were seized at their homes in southern France shortly after dawn.
- The detention could lead within hours to Mas being placed under formal investigation on suspicion of manslaughter and causing bodily harm.
Jean-Claude Mas, the Frenchman who sparked a global health scare by selling substandard breast implants, was arrested on Thursday as Marseille prosecutors build a case against him for manslaughter.
In the first arrests since the two-year-old scandal made headlines worldwide in December, Mas and a second executive at his now defunct company Poly Implant Prothese (PIP) were seized at their homes in southern France shortly after dawn.
The detention could lead within hours to Mas being placed under formal investigation on suspicion of manslaughter and causing bodily harm. That could in due course lead to criminal charges, which would carry longer sentences than those he now faces in a fraud case expected to be tried around October.
Women who have been campaigning against PIP since French authorities banned its products nearly two years ago welcomed the move as giving them a sense that the law was now in action:
"It's been too long," said Murielle Ajellio, who heads an association for women with implants. Up to now, she said: "You feel like you're fighting against the wind."
French authorities have been criticized for being slow to react to a case that has sown fear among tens of thousands of women who carry PIP implants. French inspectors ordered them off the market in March 2010, due to concerns over their quality.
But only last month did officials in Paris recommend their surgical removal, drawing attention to the problem for patients worldwide who had been fitted with products from the company, which was at one time the third biggest global supplier.
Lawyers for women in France who have filed complaints over PIP implants welcomed the arrests and said there must be no escaping justice for the 72-year-old Mas, who has been quoted as deriding those suing him as being motivated only by money.
"This is a comfort for the victims," said Laurent Gaudon, whose clients are pursuing PIP and surgeons who used its implants for fraud. "It's the feeling that justice is advancing and they have not been forgotten. It's the assurance that the guilty are at last going to be held accountable."
Philippe Courtois, who represents 1,300 people with PIP implants, said Mas should not be freed pending any trial.
Mas and PIP's former chief executive Claude Couty were questioned at home, as police conducted searches. They were then moved to police custody in the Mediterranean port city of Marseille, under the orders of prosecutor Jacques Dallest.
SUBSTANDARD SILICONE
PIP enjoyed years of success with international sales, but behind the scenes employees, and Mas himself, have admitted to hiding from certification agencies the fact they were using cheap, industrial silicone, not approved for medical use.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Public Health →Magnet hospitals better patient experiences may positively enhance reimbursement
Patients' experience with healthcare has become the focal point for quality improvement among hospitals and care providers. The Affordable Care Act incentivizes hospitals to improve patient satisfaction by paying a…
10 October 2015

